You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 27, 2024

ELIMITE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Elimite, and when can generic versions of Elimite launch?

Elimite is a drug marketed by Aurobindo Pharma Usa and is included in one NDA.

The generic ingredient in ELIMITE is permethrin. There are five drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the permethrin profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Elimite

A generic version of ELIMITE was approved as permethrin by ACTAVIS LABS on January 23rd, 1998.

  Sign Up

Drug patent expirations by year for ELIMITE
Drug Prices for ELIMITE

See drug prices for ELIMITE

Drug Sales Revenue Trends for ELIMITE

See drug sales revenues for ELIMITE

Recent Clinical Trials for ELIMITE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Saptalis PharmaceuticalsPhase 3
Saptalis Pharmaceuticals LLCPhase 3
Encube Ethicals Pvt. Ltd.Phase 3

See all ELIMITE clinical trials

Pharmacology for ELIMITE
Drug ClassPyrethroid

US Patents and Regulatory Information for ELIMITE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma Usa ELIMITE permethrin CREAM;TOPICAL 019855-001 Aug 25, 1989 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.